U.S. regulators approved Bristol-Myers Squibb Co. ’s advanced lung cancer drug Opdivo, the latest of a string of events that…
Read More
U.S. regulators approved Bristol-Myers Squibb Co. ’s advanced lung cancer drug Opdivo, the latest of a string of events that…
Read MoreLi Xiaohe has set herself up for the long haul in a cramped but sunny room in western Beijing, about…
Read MoreAntioxidant supplements are often marketed for their disease-preventing potential. Supposedly, they can eliminate free radicals and lower a person’s risk…
Read More